Xortx Therapeutics is now in the thick of things. The FDA has granted the company’s drug candidate the right to accelerated approval. Now the market is waiting for a licensing deal and the start of the decisive phase III with a partner. Xortx Therapeutics: Drug …
Read More »
Das Investor Magazin Deutsche Aktien, Rohstoffaktien & mehr
